Advances in Pharmacological Sciences. Dec/31/2017; 2018

Published online May/1/2018

PMID: 29853868

PMC: 5954929

doi: 10.1155/2018/9794625

Astragalin: A Bioactive Phytochemical with Potential Therapeutic Activities

Ammara Riaz

Azhar Rasul

Ghulam Hussain

Muhammad Kashif Zahoor

Abstract

Natural products, an infinite treasure of bioactive chemical entities, persist as an inexhaustible resource for discovery of drugs. This review article intends to emphasize on one of the naturally occurring flavonoids, astragalin (kaempferol 3-glucoside), which is a bioactive constituent of various traditional medicinal plants such as Cuscuta chinensis. This multifaceted compound is well known for its diversified pharmacological applications such as anti-inflammatory, antioxidant, neuroprotective, cardioprotective, antiobesity, antiosteoporotic, anticancer, antiulcer, and antidiabetic properties. It carries out the aforementioned activities by the regulation and modulation of various molecular targets such as transcription factors (NF-κB, TNF-α, and TGF-β1), enzymes (iNOS, COX-2, PGE2, MMP-1, MMP-3, MIP-1α, COX-2, PGE-2, HK2, AChe, SOD, DRP-1, DDH, PLCγ1, and GPX), kinases (JNK, MAPK, Akt, ERK, SAPK, IκBα, PI3K, and PKCβ2), cell adhesion proteins (E-cadherin, vimentin PAR-2, and NCam), apoptotic and antiapoptotic proteins (Beclin-1, Bcl-2, Bax, Bcl-x_L, cytochrome c, LC3A/B, caspase-3, caspase-9, procaspase-3, procaspase-8, and IgE), and inflammatory cytokines (SOCS-3, SOCS-5, IL-1β, IL-4, IL-6, IL-8, IL-13, MCP-1, CXCL-1, CXCL-2, and IFN-γ). Although researchers have reported multiple pharmacological applications of astragalin in various diseased conditions, further experimental investigations are still mandatory to fully understand its mechanism of action. It is contemplated that astragalin could be subjected to structural optimization to ameliorate its chemical accessibility, to optimize its absorption profiles, and to synthesize its more effective analogues which will ultimately lead towards potent drug candidates.

1. Introduction

Medicinal plants have been an infinite source of therapeutic agents since millions of years. Most of the discovered drugs either belong to natural products or derivatives of natural compounds [1, 2]. The actual fact is that nature is the creator of seemingly limitless series of molecular structures. These structures can serve as unlimited sources for the development of drugs, robust chemotypes, and pharmacophores which are able to be amplified into scaffolds of novel drugs for the cure of various ailments [3]. Before the advent of the postgenomic era with high throughput screening, approximately 80% of drugs were either pure extracts of medicinal plants or the semisynthetic analogues of various compounds from natural sources [4]. After the second world war, the pharmaceutical research expanded to massive screening of plant extracts in search of new drugs from natural resources [5]. To date, about 61% of anticancer and 49% of anti-infective compounds have been discovered from natural products [6].

The term “natural products” encompasses chemical entities derived from plants, bread molds, microorganisms, terrestrial vertebrates as well as invertebrates, and marine organisms [7]. These chemical entities are known to have immense chemical diversity with outstanding drug-like properties that contribute towards their multitargeted action [8]. A lot of plant-derived bioactive compounds are used for the cure as well as for the prevention of several diseases. Among these compounds are the polyphenols consisting of alcohols with ≥2 benzene rings and ≥1 hydroxyl group. These polyphenols have a range from simple structural molecules (flavonoids and phenylpropanoids) to highly complex compounds (lignins and melanins). Reports have suggested that polyphenols in general and flavonoids in particular exhibit various biological effects like antiallergic, antibacterial, anti-inflammatory, antiviral, antithrombic, hepatoprotective, antibacterial, and antioxidant activities [9].

Flavonoids are structurally diverse and most abundantly found polyphenols in the human diet [10]. They are mostly found in the form of glycosides and acylglycosides. Flavonoids have been divided into various classes such as flavones, flavonols, flavanones, flavanonols, flavanols or catechins, and anthocyanins. They are the essential constituents of our food and are found in onions, parsley, berries including blue berries, black tea, green tea, bananas, red wine, all citrus fruits, sea blackthorns, and dark chocolates with the contents of 70% or more [11].

Astragalin (kaempferol-3-O-β-D-glucoside), a bioactive natural flavonoid, has been well known for its medicinal importance. It has been reported to exhibit multiple pharmacological properties including antioxidant [12, 13], anti-inflammatory [14], anticancer [15], neuroprotective [16], and cardioprotective property [16].

2. Natural Sources of Astragalin

Astragalin, a naturally occurring flavonoid, has been identified in a variety of plants (Figure 1 and Table 1) such as Cuscuta chinensis Lam., a member of the Convolvulaceae family, which consists of about 60 genera and 1,650 species. The seeds of the genus Cuscuta are a rich source of astragalin and are utilized as a traditional folk medicine to cure osteoporosis in various Asian countries including Pakistan [17]. C. chinensis has high contents of astragalin, that is, 29–34% of total phenolics as compared to other species [18]. Cassia alata belongs to the family Fabaceae (the largest family among angiosperms) that comprises of ∼700 genera and 20,000 species. The leaves of C. alata are found to be effective against skin diseases including eczema and chronic skin impurities in tropical regions of the world (Malaysia, Brazil, and Indonesia) [19]. Astragalin has also been isolated from the plants of Ebenaceae, Rosaceae, and Eucommiaceae families. The summary of plants containing astragalin, parts utilized, and biological features are enlisted in Table 1.

Astragalin can also be produced in vivo by glycosylation of kaempferol at the 3C-O position [20]. UDP-dependent glycosyltransferases (UGT) were used as biocatalysts in the synthesis of astragalin. A recombinant strain of Arabidopsis thaliana was used to construct an efficient UDP-glucose synthesis pathway by use of enzymes such as uridylyltransferase, sucrose phosphorylase, and sucrose permease. BL21-II was a recombinant strain designed to scale up the production of astragalin by using a fed-batch fermentator.

3. Biological Activities of Astragalin and Their Mechanisms of Action

The biologically active and therapeutically effective compound “astragalin” has been known to possess broad spectrum of pharmacological features such as anticancer, anti-inflammatory, antioxidant, neuroprotective, antidiabetic, cardioprotective, antiulcer, and antifibrotic as shown in Figure 2. Various in vivo and in vitro investigations on astragalin have elucidated its medicinal characteristics and mechanism of actions.

3.1. Anti-inflammatory Activity

Inflammation is an immediate response of a body to tissue damage caused by pathogens and toxic stimuli such as physical or chemical injury. Although inflammatory response is a defense mechanism, but if persistent, it can lead to multiple pathological conditions such as cancer, allergy, atherosclerosis, and autoimmune diseases [119]. Negative after effects associated with nonsteroidal type anti-inflammatory drugs (NSAIDs) arouse a need among researchers to find out effective and safe alternatives [120]. Plant extracts enriched with flavonoids have been known to possess anti-inflammatory activity [121].

Astragalin, a bioactive natural flavonoid, has been known to mitigate inflammation in LPS-induced murine model of mastitis and lung injury model via reducing the activity of myeloperoxidase and the expression of IL-1β, IL-6, and TNF-α. Astragalin's anti-inflammatory response proceeds via inhibition of LPS-induced activation of NF-κB, as it is actively involved in alleviating the deterioration of IkBα and restricting the nuclear translocation of NF-κB [92, 122]. Another investigation on LPS-stimulated expression of inflammatory mediators in macrophages has declared the fact that astragalin actively inhibited the expression of proinflammatory mediators via inhibiting NF-κB signaling pathway [123]. Astragalin has been known to halt the MAPK and NF-κB pathways in leptospira-induced uterine and epithelial inflammation in mice [124]. Astragalin has capability to inhibit the production of prostaglandin E2 (PGE2) in periodontal pathogen-induced periodontitis, a destructive inflammatory pathological condition, in human gingival epithelial cells [125]. Astragalin has been investigated to determine the underlying mechanism for its protective effect against ovalbumin-stimulated allergic reactions in mouse models of allergic asthma. Results have declared that it effectively lowers the eosinophil count in lung tissues and inhibited eosinophilia induced by ovalbumin. As a result, IgE, IL-4, IL-5, and IL-13 were retrieved in bronchoalveolar lavage fluid [126]. Purely prepared astragalin inhibited the activity of PGE2 and downregulated the production of cellular nitrite oxide and IL-6 in LPS-stimulated RAW 264.7 cells [33]. Astragalin treatment leads to the inhibition of alveolar destruction, allergic inflammation, and thickening of airways in the ovalbumin-induced inflammatory mouse model [14]. Anti-inflammatory activities of astragalin in different animal models are recorded in Table 2.

3.2. Antioxidant Activity

In living systems, free radicals such as hydroxyl radicals (OH·), superoxide anion (O₂·−), singlet oxygen (¹O₂), and ROS are reported to have deleterious impacts on cellular functions. Excessive production of free radicals may affect the balance of prooxidant and antioxidant systems in the body, thus causing various pathological conditions such as arterial hypertension, rheumatism, inflammation, diabetes, cancer, neurodegenerative disorders, and genetic mutations [120]. Researchers have affirmed various plant extracts as natural and infinite treasure of antioxidants. These antioxidants act as free radical scavengers, electron donors, and chelating agents for free catalytic metals in biological systems [75].

Astragalin also inhibits the endotoxin-induced oxidative stress, which can lead to epithelial apoptosis and eosinophilia. It can also act as an antagonizing agent against endotoxin-induced oxidative stress via modulation of LPS-TLR signaling network [129]. Astragalin causes the suppression of 6-hydroxydopamine-stimulated neurotoxicity in Caenorhabditis elegans via modulation of apoptosis-related pathways and alleviation of oxidative stress [130]. Astragalin has capability to improve neural function in the ischemia brain injury model of rats via blocking the apoptosis in the hippocampus region by enhancing the expression of NCam [131] (Table 3).

3.3. Neuroprotective Activity

Disturbance in cerebral redox homeostasis is the main cause of neurodegenerative diseases in humans. Cerebral oxidative stress leads to dopaminergic neuronal cell death and dysfunction. Neuroprotective mechanism of naturally occurring bioactive entities is associated with their free radical scavenging capability generated by neurotoxins and oxidative stress-induced processes in neuronal cells of the brain [133].

Astragalin has been reported to decrease the neurodegeneration in C. elegans stimulated by 6-OHDA and increase lifespan of astragalin-treated nematode. It also reduces the ROS levels, inhibits lipid peroxidation, and increases SOD and GPx activities. Furthermore, it is capable of enhancing AChE and reducing the transcript level of proapoptotic gene egl-1 associated with neuronal cell death [130]. In another attempt, the effects of astragalin on CNS were assessed by the application of the leaves extract of Eucommia ulmoides. The extract with high percentage of astragalin had a significant effect on metabolism of mice. Moreover, it effectively prolonged the convulsion latency and diminished the convulsion rate. These results strengthen the fact that E. ulmoides has a very good hypnotic effect on CNS [49]. Astragalin also suppressed carrageenan-stimulated paw edema in rats. Neural function is also reported to be improved by the use of astragalin in ischemic brain injury rat models [131].

3.4. Cardioprotective Activity

Myocardial infarction and ischemic heart failure are the leading causes of mortality in the developing countries, and their number is increasing day-by-day. They may result in reperfusion arrhythmias, myocardial stunning, and similar other cardiovascular disorders [16]. An enhanced perception of ischemia reperfusion (I/R) damage provides an innovative approach for new cardioprotective administrations [134]. Regulation of bradykinin, adenosine, opioid, adrenergic, and other G-protein connected receptors have been known to be associated with myocardial protection [135].

Certain epidemiological studies have confirmed that flavonoids stimulate cardioprotective effects against myocardial ischemia [136]. Astragalin, a bioactive flavonoid, was proved to be effective against acute I/R injury in Sprague-Dawley rats as its mechanism of action precedes via diminishing intracellular oxidative stress and apoptosis. The associated mechanism involves decreased expression of MDA, TNF-α, IL-6, ROS, and Bax along with the increased ratio of GSH/GSSG, respectively [137].

3.5. Antiobesity Activity

The term “obesity” can be defined as impaired energy balance that usually results from either enhanced caloric intake and/or reduced energy consumption. Currently, much attention has been given to several nutritional aspects that may be useful for inhibiting body fat accumulation and decreasing the risk of diseases related to obesity. In case of mammals, energy metabolism is maintained by lipolytic action in adipose tissues which is generally stimulated by some pharmacologically important lipolytic hormones such as nor-epinephrine, epinephrine, and catecholamines [80]. Many cellular investigations have determined that dietary polyphenols decrease viability of adipocytes and growth of preadipocytes, downregulate triglyceride accumulation and adipocyte differentiation, and induce fatty acid beta-oxidation and lipolysis [138].

Astragalin along with other known flavonoids isolated from N. nucifera showed inhibitory effect on diet-induced obesity and also activated β-adrenergic receptor pathway, but additional experimentation is required to fully elucidate its possible mechanism of action [80].

3.6. Antiulcer Activity

Ulcer is a chronic lesion which usually develops due to an imbalance between numerous protective and aggressive factors. Gastric ulcers being represented by repeated incidents of healing and reexacerbation contribute towards chronic inflammation which may persist for 10–20 years. It is a well-known fact that naturally occurring phenolic entities have capability to shield gastric mucosa from injury due to their cytoprotective and antioxidant features. Furthermore, flavonoids stimulate mucus secretion, block pepsinogen, prohibit Ca²⁺ influx, and also change GSH metabolism. Astragalin, a pharmacologically active flavonoid isolated from C. cyparissias, has been examined for its antiulcer activity. Results demonstrated that 30 mg/kg dosage of astragalin effectively decreases percentage of lesion area, total area of lesion, and ulcer index in the mice model of gastric secretion [97].

3.7. Antidiabetic Activity

Diabetes mellitus is characterized by hyperglycemia which is caused by deficit in insulin action or production [139]. Currently available antidiabetic therapeutics such as hypoglycemic drugs and insulin have limitations of their own. Natural products and herbal medicines have been suggested as one of the treatment options for diabetes since ancient times. Naturally occurring bioactive chemical entities such as flavonoids, terpenoids, alkaloids, and phenolics have been reported as antidiabetic agents [140].

Diabetic retinopathy (DR) arises due to diabetes mellitus and is one of the most common causes of vision loss. Hyperglycemia leads to overexpression of many biological effectors such as vascular endothelial growth factor (VEGF) which is very crucial for the development of DR. Astragalin derived from A. membranaceus has beneficial effects against hyperglycemia. It helps to prevent DR by decreasing the overexpression of VEGF in cultured muller cells and alleviating the effects caused by high concentration of glucose in the blood [141].

3.8. Antifibrotic Activity

Environmental factors like air pollutants may result in considerable production of reactive oxygen species in the airways. Astragalin isolated from leaves of persimmon and green tea can be effectual in allaying ROS-prompted bronchial fibrosis as it has capability to inhibit auto phagosome formation in the airways [132]. It also alleviates hepatic fibrosis by regulating PAR2 (protease-activated receptor 2) mechanism. AGS regulates proinflammatory cytokines namely IL-6, IL-1β, and TNF-α. It also attenuates the PAR2 signaling expression, and its protective effects are especially prominent in diabetic animal models [128].

3.9. Cosmetic Use

Astragalin glucosides can be used as valuable agents in cosmetics due to their important chemical characteristics. First of all, it inhibits collagenase activity. Collagenase is involved in the hydrolyzation of dermal matrix protein formation as well as wrinkle formation. Secondly, astragalin has an antioxidant activity as it alleviates the free radical species. Thirdly, astragalin controls the pigmentation in the skin caused by melanin [142]. Melanin pigment causes darkening of complexion in skin, eyes, and hair in humans. Nelumbo nucifera (lotus) contains bioactive compounds astragalin and hyperoside in the receptacles which are known to be the melanogenesis inhibitor, thus possibly decreasing the skin darkness [143]. Astragalin along with quercetin is known to possess protective effect against the UV radiations. UV radiations can make the skin of animals prone to various biological responses such as DNA damage, formation of sunburn cells, melanogenesis, photoaging, skin cancer, hyperplasia, immune suppression, and edema. UV radiations from the sun can also damage macromolecules in the epidermal layer of animals creating specific changes in the skin, for example, mutations in genes and changes in the immune system. Expression of major CXC chemokines, that is, chemokine ligand 1 (CXCL1) and chemokine ligand 2 (CXCL2), at sites of inflammation within the skin are upregulated after the exposure of skin to UV radiations. These chemokines are the potent stimulators of neutrophil activation which later on produce ROS and leads to oxidative stress. Astragalin, a major flavonoid, can be used as a barrier against UV-induced damage as it is associated with downregulation of CXCL-1 and CXCL-2 in the skin and thus can be used as a photoprotective agent [144] (Table 4).

3.10. Antiosteoporotic Activity

Osteoporosis is characterized by structural deterioration of tissues in the bone along with lower bone mass and bone fragility. The main causes of osteoporosis include estrogen deficiency, excess of glucocorticoids, and oxidative stress. Astragalin, an active compound, isolated from crude methanolic extract of the seeds of C. chinensis showed estrogenic activity against osteoporosis, and it is responsible for significant osteoblastic cell proliferation in UMR-106 osteoblastic cells [17].

3.11. Anticancer Activity

Currently, cancer is the second leading cause of mortality worldwide. In spite of advances in the development of new therapeutic preferences for cancer, its ratio is increasing day by day. Every year, almost 7 million people die due to cancer. Lung cancer particularly non-small cell lung cancer (NSCLC) accounts for more than 80% of deaths all around the world today. Therefore, it is necessary to discover new cheap and inexpensive drugs that can ameliorate the antitumor effects and reduce the side effects of generally recommended chemotherapy drugs [145].

Natural phytochemicals that are active constituents of medicinal plants, seeds, fruits, and herbs including polyphenols (flavonoids, terpenoids, and carotenoids) have gained significant recognizance for their potential value as therapeutic agents [146, 147]. Much research work has been conducted towards the assessment of phenolic phytochemicals as potent prophylactic agents as they can act on multiple cellular targets. The mechanistic insight into chemoprevention incorporates induction of apoptosis and cell cycle arrest or prohibition of certain cell signaling pathways mostly protein kinases C (PKC), glycogen synthase kinase (GSK), mitogen-activated protein kinases (MAPK), and phosphoinositide 3-kinase (PI3K) leading to abnormal AP-1, COX-2, and NF-κB expressions. Efficacy of chemopreventive agents revert their capacity to counteract with certain up-stream signals that leads to redox imbalances, genotoxic injury, and other situations of cellular stress. Thus, targeting damaged molecules along with interrupted signal transduction pathways in cancer epitomize a rational strategy for chemoprevention, and phenolic compounds seem to be auspicious in this aspect [147, 148]. In recent years, flavonoids have drawn developing consideration as powerful anticancer agents against various cancer types [149].

Several investigations on astragalin have explained its anticancer effect due to its promising competency to inhibit proliferation in different cancer cell lines including leukemia (HL-60) [15], hepatocellular (HepG2, Huh-7, and H22) [150], skin (HaCaT, A375P, and SK-MEL-2) [151], and lung (A549 and H1299) cancerous cells [145].

Astragalin heptaacetate (AHA), a therapeutically active flavonoid, induces apoptosis in HL-60 cells through release of cytochrome c into the cytosol. The associated mechanism involves activation of Bax, caspase-3/-7, and p38MAPK and intracellular ROS generation along with inhibition of cell signaling pathways JNK/SAPK and ERK ½ [15]. Astragalin also prohibits TNF-α-induced NF-κB activation in A549 and H1299 cells. Moreover, AG-triggered cell death is affiliated with increased Bax : Bcl-2 ratio and enhanced cleavage of caspase-3/-9 and PARP in conjunction with blockage of PI3K/Akt, MAPK, and ERK 1/2 signaling cascades in a time- and dose-related manner [145]. In hepatocellular carcinoma cells, astragalin (AG) significantly suppressed proliferation both in vitro in HepG2 cells and in vivo in Huh-7 (nude mice) and H22 (Kunming mice) cells via mechanistically inhibiting hexokinase 2 and upregulating miR-125b expression, respectively [150].

Astragalin can be a novel anticancer agent for the cure and prevention of UVB-stimulated actinic keratosis skin lesion by suppressing phospho-MSK1, γ-H2AX, and p38MAPK activation in a time-and dose-related manner in human HaCaT cells in vitro and Babl/c mice in vivo. In another report, astragalin strongly exerted cytotoxic effects in A375P and SK-MEL-2 cancerous cells in a concentration-dependent way through induction of apoptosis. The underlying cell death mechanism involves activation of Bax and caspase-3/-9, cleavage of PARP, and downregulation of cyclin D1 and Mcl-1 along with inhibition of Sry-related HMg-Box Gene 10 (SOX10) signaling cascade [151, 152]. The reported data recommend astragalin's multitargeted activity in preference to single effect that may perform an imperative role towards developing astragalin into potential anticancer drug in future (Table 5).

4. ADMET Profiles of Astragalin

ADMET profiles along with biological activity spectra were performed for astragalin based on in-silico tools. The results indicate that astragalin is a potential anticancer agent which is unlikely to present any acute hazard or toxicity. Furthermore, astragalin can be absorbed by human intestines, but it is incapable of penetration to Caco-2 cells. Astragalin has been validated as a novel substrate of p-glycoprotein which is crucial for the metabolism and clearance of the compounds and for the efflux of drugs [154].

5. Conclusions and Future Perspectives

Astragalin, a natural flavonoid, has been isolated from various traditional medicinal plants such as Cassia alata, Moringa oleifera, Nelumbo nucifera, Cuscuta spp., Radix astragali, Morus alba, and Eucommia ulmoides. Astragalin has been reported to modulate inflammatory responses by regulating the expression of NF-κB, iNOS, cytokines/chemokines (COX-2, TNF-α, IL-10, and IL-6), MAPK signaling pathways (PGE2, IgE, IL-4, IL-5, IL-13, IL-1β, and IL-6), and PAR2 signaling expression. It also has the capability to alleviate the production of ROS and inhibit the endotoxin-induced oxidative stress (Figure 3). Astragalin is also known to be an inhibitor of ERK-1/2 and Akt signaling; therefore, it is a significant compound against cancer proliferation. In this review paper, we have emphasized on various pharmacological properties of astragalin such as anti-inflammatory, antioxidant, neurological, cardioprotective, antidiabetic, and anticancer. Although several in vitro and in vivo investigations have demonstrated its diversified pharmacological applications, further experimentation along with medicinal chemistry approaches and preclinical trials is still obligatory to uncover the knowledge of its biological and pharmacological applications and their associated mechanisms of actions for the treatment and prevention of several diseases.

Figure 1

Natural sources of astragalin.

Figure 2

Biological activities of astragalin.

Figure 3

A diagrammatic representation of molecular targets and mechanism of action of astragalin. Astragalin has capability to modulate various transcriptional factors, enzymes, protein kinases, cell adhesion molecules, apoptotic and antiapoptotic proteins, and inflammatory cytokines resulting in anticancer, anti-inflammatory, antioxidant, and cardioprotective activities.

Table 1

Plants containing astragalin as an important constituent with its biological properties.

Name of the plant		Parts used/extract	Biological activities	References
Botanical name	Common name	Parts used/extract	Biological activities	References
Acer truncatum	Shantung maple	—	—	[21]
Aceriphyllum rossii	Mukdenia	Aerial parts	Antioxidant	[22]
Agrimonia pilosa	Hairy agrimony	Aerial parts	Antihemorrhagic, antiplatelet, antioxidant, and acetylcholinesterase inhibitory	[23]
Allium ursinum	Wild garlic	Flowers	Antimicrobial	[24]
Allium victorialis	Alpine leek	—	Antitumor	[25]
Alsophila spinulosa	Hook tryon	Leaves	Antixanthine oxidase	[26]
Apocynum venetum	Luobuma	Leaves	Lower blood pressure, antidepressant, antinephritis, and antineurasthenia	[27]
Jasminum subtriplinerve Blume	—	Aerial parts	—	[28]
Astragalus hamosus	Dwarf yellow milk vetch	Aerial parts	—	[29]
Caesalpinia decapetala	Mysore thorn	Leaves	—	[30]
Calligonum polygonoides	Phog	Aerial parts	Antiulcer, anti-inflammatory, hypoglycemic, and antioxidant	[31]
Camellia sinensis	Tea	Leaves and seeds	Antidysentery, antihyperlipidemia, antihyperglycemia, and anti-inflammatory	[32–35]
Carthamus lanatus L.	Downy safflower	Aerial parts	Antioxidant	[35]
Cassia alata	Ringworm bush	Leaves	Antioxidant, anti-infectious, and DNA repair	[19]
Celastrus gemmatus Loes	Chinese bittersweet	Leaves	—	[36]
Centella asiatica	Asiatic pennywort	Leaves	Anti-inflammatory	[37]
Clerodendrum philipinum	Chinese glory bower	Roots	—	[38]
Conyza filaginoides	Laennecia filaginoides	Aerial parts	Antiprotozoal	[39]
Corchorus olitorius L.	Moroheiya	Leaves	Inhibits the histamine	[40]
Cuscuta chinensis	Chinese dodder	Seeds	Antiosteoporotic	[17, 41–43]
Cuscuta australis	Australian dodder	Seeds	—	[17, 41–43]
Diodia teres	Buttonweed	Whole plant	—	[44]
Drosera peltata	Sundew		Antitussive	[45]
Dianthus barbatus cv	Sweet William	Aerial parts	Anti-inflammatory	[46]
Eucommia ulmoides	Hardy rubber tree	Leaves	Antidiabetic, antioxidant, and hypnotic effect	[47–49]
Eupatorium cannabinum L.	Hemp agrimony	Aerial parts	—	[50]
Eupatorium lindleyanum		Aerial parts	—	[51]
Exochorda racemosa	Pearlbrush	—	—	[52]
Flaveria bidentis (L.) Kuntze	Coastal plain yellow tops	Leaves	—	[53, 54]
Flos gossypii	—	Flowers	—	[55]
Gladiolus gandavensis	Gladiolus	Aerial parts	—	[56]
Glycyrrhiza glabra	European licorice	Leaves	—	[57]
Glycyrrhiza uralensis Fisch	Chinese licorice	Leaves	—	[58]
Gynura procumbens	Longevity spinach	—	Antidiabetic	[59]
Hedera helix	English ivy	—	—	[60]
Helianthemum glomeratum	Island rushrose	Aerial parts	—	[61]
Hemistepta lyrata Bunge	—	Whole plant	—	[62]
Hippophae rhamnoides L.	Sea buckthorn	Leaves	—	[63]
Ipomoea batatas	Sweet potato	Leaf	—	[64]
Koelreuteria paniculata	Golden rain tree	Flowers	Antioxidant	[65]
Allium ampeloprasum	Wild leek	Leaves	Antioxidant	[66]
Ligusticum chuanxiong	—	Aerial parts	—	[67]
Lindera aggregate	Evergreen lindera	Leaves	—	[68]
Litsea coreana	—	Leaves	Antioxidant	[69]
Magnolia fargesii	—	Flowers	Anticomplement	[70]
Moringa oleifera Lam.	Drumstick tree	Leaves	Antioxidant	[71]
Morus alba L.	White mulberry	Leaves	Hypoglycemic and antioxidant	[72–78]
Mussaenda arcuate	Forest star	Leaves		[79]
Nelumbo nucifera	Sacred lotus	Leaves	Lipolytic activity	[80–84]
Ochradenus baccatus	Taily weed	Aerial parts	—	[85]
Orostachys japonica	Rock pine	—	Calpain inhibitory activity	[86]
Diospyros kaki	Japanese persimmon	Leaves	Angiotensin converting enzyme activity, and inhibition of atopic dermatitis (AD)	[12, 87–89]
Rosa agrestis	Field briar	Leaves	Anti-inflammatory and antioxidant	[13, 90–92]
Peucedanum alsaticum	—	Fruits	—	[93]
Phaseolus vulgaris L.	Common bean		—	[94]
Phlomis spinidens	—	Aerial parts	Antiallergic	[95]
Phyllanthus muellerianus	—	Leaves	Antibacterial and anti-inflammatory	[96]
Polygala cyparissias	—		Antiulcer	[97]
Polygonum salicifolium	Knotweed	Aerial parts	DPPH-free radical scavenging activity	[98]
Prunus padus L.	European bird cherry	Flowers and leaves	Antioxidant	[99]
Prunus serotina Ehrh	Black cherry	Leaves and flowers	—	[100]
Pseudotsuga menziesii	Oregon pine	Needles	Cytotoxic	[101]
Radix astragali	Milk vetch root	Roots	Antidiabetic	[102–104]
Rhus sylvestris	Sumach	Stems and leaves	Antiosteoporotic	[105]
Rosa soulieana	Shrub rose	Flowers	Antioxidant	[106]
Rubus rigidus var. camerunensis	Ronce blanche	Aerial parts	Antioxidant	[107]
Sapium sebiferum	Chinese tallow	Leaves	—	[108]
Solenostemma argel	Arghel	Aerial parts	Antibacterial	[109]
Solidago canadensis L.	Canada goldenrod	—	Antioxidant	[110]
Sorbus aria (L.)	Lutescens	Leaves	—	[111]
Tadehagi triquetrum	—	Whole plant	Antimicrobial and anti-inflammatory	[112]
Tiarella polyphylla	Foam flower	Whole plant	—	[113]
Trachelospermum jasminoides	Confederate jasmine	Leaves	Antifungal	[114]
Urtica cannabina	—	Fruits	—	[115]
Vahlia capensis	—	—	Antibacterial	[116]
Vicia calcarata	Few flowered vetch	Aerial parts	Hepatoprotective	[117]
Wedelia chinensis	—	Whole plant	Inhibitor of the complement system	[118]

Table 2

Anti-inflammatory activities of astragalin in vitro and in vivo.

Assay	Organism tested	Dose/concentration	Molecular targets	References
LPS-induced mouse mastitis	Mouse mastitis	10, 25, and 50 mg/kg	TNF-α^↓, IL-1β^↓, IL-6^↓, p65^┴, and IκBα^┴	[92]
LPS-induced endotoxemia and lung injury in mice	Mice (lung)	25, 50, and 75 mg/kg	TNF-α^┴, IL-1β^┴, and IL-6^┴	[122]
LPS-induced macrophages in mice	Mouse cells	1–100 µg/mL	iNOS^↓, COX-2^↓,TNF-α^↓, IL-1β^↓, IL-6^↓, MIP-1α^↓, MCP-1^↓, NF-κB p65^┴, IκBα^┴, and NO^┴	[127]
LPS-induced RAW 264.7 cells.	Mice (RAW 264.7 cells)	1, 10, and 100 μM	NO^↓ and TNF-α^↓	[37]
Inhibitory activity on the histamine release by KU812 cells	KU812 cells	10 to 30 μmol/L	IL-4^↓, IL-13^↓, and (IFN-γ) no effect	[12]
LPS-induced inflammation in RAW 264.7 cells	Mice (RAW 264.7 cells)		NO^┴, IL-6^┴, and PGE2^┴	[33]
P. gingivalis-induced human gingival epithelial (HGE) cells	Human gingival epithelial cells		COX-2^┴, IL-6^┴, IL-8^┴, MMP-1^┴, MMP-3^┴, PGE-2^┴, and IL-4^┴	[125]
Anti-inflammatory effects on Leptospira interrogans-induced inflammatory response	Uterine and endometrial epithelial cells of mice	100 μg/mL	TNF-α^┴, IL-1β^┴, IL-6^┴, NF-κB^↓, p38^┴, p-p38 MAPK^↓, ERK^┴, JNK^┴, and p-p65^↓	[124]
Protective effects against ovalbumin- (OVA-) induced allergic inflammation	Mouse model of allergic asthma	0.5 mg/kg and 1 mg/kg	SOCS-3^┴, SOCS-5^┴, and IFN-γ^↑	[126]
Alleviation in hepatic fibrosis function	Diabetic rats and nondiabetic rats		PAR2^┴, IL-1β^↓, IL-6^↓, TNF-α^↓, and TGF-β1^┴	[128]
Prevention from atopic dermatitis	NC/Nga mice	1.5 mg/kg	IgE^↓	[87]

^↑Upregulation; ^↓downregulation; ^┴inhibition.

Table 3

Antioxidant activity of astragalin in vitro and in vivo.

Assay	Organism tested	Dose/concentration	Molecular targets	References
Free radical-scavenging activity		1, 3, 10, 30, 100, or 300 µg/mL		[107]
Inhibitory activity against autophagy-associated airway epithelial fibrosis	Mice	1–20 μM	E-cadherin^┴, vimentin^┴, Beclin-1^↓, LC3A/B^↓, EMT^↓, and TGF-β1^┴	[132]
Apoptotic and eosinophilia amelioration	BEAS-2B cells	1–20 μM	TLR-4^↓, Eotaxin-1^↓, PLCγ1^↓, PKCβ2^↓, p-p22^↓, p-47^↓, JNK^↓, p38 MAPK^↓, Akt^↑, and ERK^↑	[129]
Suppression of 6-hydroxydopamine-induced neurotoxicity in Caenorhabditis elegans	C. elegans	2.0 mg/mL	egl-1^↓, SOD^↑, GPX^↑, AChe^↑, and p38 MAPK^↓	[130]
Neuroprotective effect against ischemic brain injury	Wister rats	5 mg/kg and 15 mg/kg	NCam^↑	[131]

^↑Upregulation; ^↓downregulation; ^┴inhibition.

Table 4

Cosmetic uses of astragalin.

Assay	Organism tested	Dose/concentration	Molecular targets	References
Inhibition of melanin secretion	Leuconostoc mesenteroides	10 mM	MMP-1^┴	[142]
Protection against UV damage	Mice (BalB/c) and human keratinocyte cells (HaCaT cells)	2.5 mg/kg and 0.25 µM/ml	CXCL-1^↓ and CXCL-2^↓	[144]

^↓Downregulation; ^┴inhibition.

Table 5

Anticancer activities of astragalin in vitro and in vivo.

Type of cancer	Cell line	Dose/concentration	Molecular targets	References
Leukemia	HL-60	6 ± 1 µM	Bax^↑, Bcl-2^↓, caspase-3/-7^Act, JNK/SAPK^┴, and ERK 1/2^┴	[15]
Hepatocellular	HepG2, Huh-7, and H22	—	HK2^┴ and miR-125b^↑	[150]
Skin	HaCaT, A375P, and SK-MEL-2	50 and 100 μM/mL	p38 MAPK^↓, phospho-MSK1^↓, γ-H2AX^↓, caspase-9/-3^Act, Bax^Act, PARP cleavage, cyclin D1^↓, Mcl-1^↓, and SOX10^┴	[151, 152]
Lung	A549, H1299, H226, H838, H23, H1437, H125, H2009, and H2087	5, 40 µg/mL (A549) and 20 µg/mL (H1299)	Bax:Bcl-2^↑, caspase-9/-3^↑, p-IKK-β^↓, NF-κB p65^┴, TNF-α^┴, ERK-1/2^┴, JNK^↑, PI3K/Akt^┴, DDH^┴, DRP-1^↓, pro-caspase-3/-8^↑, and Bax^↑	[145, 153]
Breast	ZR-75-1, T47D, BT20, MCF-1, and MCF-7	—	DDH^┴, DRP-1^↓, pro-caspase-3/-8^↑, and Bax^↑	[153]
Gastric	AGS, SC-M1, NUGC-1, NUGC-3, and KOTA-III	—	DDH^┴, DRP-1^↓ pro-caspase-3/-8^↑, and Bax^↑	[153]

^↑Upregulation; ^↓downregulation; ^┴inhibition.

Acknowledgments

This study was supported by the research grant from The Nagai Foundation, Tokyo, Japan (NFT-R4-2017 and NFT-R4-2018) and TWAS-COMSTECH Research Grant (no. 17-180 RG/PHA/AS_C). The authors would also like to thank Higher Education Commission (HEC), Pakistan, for providing access to related papers from various journals.

Conflicts of Interest

The authors declare that there are no conflicts of interest.

Abbreviations

Ache:Acetylcholinesterase

Bax:Bcl-2 associated protein

Bcl-2:B-cell lymphoma-2

COX-2:Cyclooxygenase-2

CXCL-1:Chemokine-1

CXCL-2:Chemokine-2

DAF-16:Abnormal dauer formation

DDH:Dihydrodiol dehydrogenase

DRP-1:Dynamin-related protein-1

E-cadherin:Epithelial cadherin

EMT:Epithelial to mesenchymal transition

Eotaxin-1:Eosinophil chemotactic protein

ERK:Extracellular signal-regulated kinase

GPX:Glutathione peroxide

GSH:Glutathione

HK2:Human kallikrein-related peptidase-2

IFN-γ:Interferon gamma

IgE:Immunoglobin E

IL-13:Interleukin-13

IL-1β:Interleukin-1 beta

IL-4:Interleukin-4

IL-6:Interleukin-6

IL-8:Interleukin-8

iNOS:Inducible nitric oxide synthase

IκBα:Inhibitor of kappa B alpha

JNK:c-Jun N-terminal kinase

LC3A/B:Microtubule-associated protein 1 light chain 3A/B

MAPK:Mitogen-activated protein kinase

Mcl-1:Myeloid cell leukemia 1

MCP-1:Monocyte chemoattractant protein-1

MIP-1α:Macrophage inflammatory protein 2-alpha

miR-125:MicroRNA-125

MMP:Mitochondrial membrane potential

MMP-1:Matrix metalloproteinase-1

MMP-3:Matrix metalloproteinase-3

NCam:Neutral cell adhesion molecule

NO:Nitric oxide

PAR2:Protease-activated receptor 2

PGE2:Prostaglandin E2

PI3K:Phosphoinositide-3

PKCβ2:Protein kinase C beta-2

PLCγ1:

Phosphoinositide phospholipase C γ1

SAPK:Stress-activated protein kinase

SOCS-3:Suppressor of cytokine signaling 3

SOCS-5:Suppressor of cytokine signaling 5

SOD:Superoxide dismutase

SOX10:Sry-related HMg-Box gene 10

TGF-β1:Transforming growth factor beta 1

TLR-4:Toll-like receptor 4

TNF-α:Tumor necrosis factor alpha.

References

1. NewmanD. J.CraggG. M.Natural products as sources of new drugs over the 30 years from 1981 to 201020127575311335[PubMed]
2. KingstonD. G.Modern natural products drug discovery and its relevance to biodiversity conservation20117474496511[PubMed]
3. VeereshamC.Natural products derived from plants as a source of drugs201233200201[PubMed]
4. KatiyarC.GuptaA.KanjilalS.KatiyarS.Drug discovery from plant sources: an integrated approach201233331019[PubMed]
5. HarveyA. L.Natural products in drug discovery20081313894901[PubMed]
6. LuoY.CobbR. E.ZhaoH.Recent advances in natural product discovery20143030230237[PubMed]
7. RasulA.MillimounoF. M.Ali EltaybW.AliM.LiJ.LiX.Pinocembrin: a novel natural compound with versatile pharmacological and biological activities201320139[PubMed]
8. HongJ.Role of natural product diversity in chemical biology20111515350354[PubMed]
9. AruomaO. I.GrootveldM.BahorunT.Free radicals in biology and medicine: from inflammation to biotechnology2006272713[PubMed]
10. PrasainJ. K.BarnesS.Metabolism and bioavailability of flavonoids in chemoprevention: current analytical strategies and future prospectus200744846864[PubMed]
11. SpencerJ. P.Flavonoids: modulators of brain function?2008991ES60ES77[PubMed]
12. KotaniM.MatsumotoM.FujitaA.Persimmon leaf extract and astragalin inhibit development of dermatitis and IgE elevation in NC/Nga mice2000106106159166[PubMed]
13. BitisL.KulturS.MelikogluG.OzsoyN.CanA.Flavonoids and antioxidant activity of Rosa agrestis leaves20102424580589[PubMed]
14. KimY. H.ChoiY. J.KangM. K.Astragalin inhibits allergic inflammation and airway thickening in ovalbumin-challenged mice20176565836845[PubMed]
15. BurmistrovaO.QuintanaJ.DiazJ. G.EstevezF.Astragalin heptaacetate-induced cell death in human leukemia cells is dependent on caspases and activates the MAPK pathway20113093097177[PubMed]
16. BaineyK. R.ArmstrongP. W.Clinical perspectives on reperfusion injury in acute myocardial infarction2014167167637645[PubMed]
17. YangL.ChenQ.WangF.ZhangG.Antiosteoporotic compounds from seeds of Cuscuta chinensis2011135135553560[PubMed]
18. DonnapeeS.LiJ.YangX.Cuscuta chinensis Lam.: a systematic review on ethnopharmacology, phytochemistry and pharmacology of an important traditional herbal medicine2014157157292308[PubMed]
19. SaitoS.SilvaG.SantosR. X.GosmannG.PungartnikC.BrendelM.Astragalin from Cassia alata induces DNA adducts in vitro and repairable DNA damage in the yeast Saccharomyces cerevisiae2012131328462862[PubMed]
20. PeiJ.DongP.WuT.Metabolic engineering of Escherichia coli for astragalin biosynthesis2016In Press
21. HuangX. Z.TanL. X.GuK.LiC.Studies on chemical constituents from leaves of Acer truncatum2007323215441546
22. HanJ. T.BangM. H.ChunO. K.KimD. O.LeeC. Y.BaekN. I.Flavonol glycosides from the aerial parts of Aceriphyllum rossii and their antioxidant activities20042727390395[PubMed]
23. KatoH.LiW.KoikeM.WangY.KoikeK.Phenolic glycosides from Agrimonia pilosa2010717119251929[PubMed]
24. IvanovaA.MikhovaB.NajdenskiH.TsvetkovaI.KostovaI.Chemical composition and antimicrobial activity of wild garlic Allium ursinum of Bulgarian origin20094410591062
25. LeeK. T.ChoiJ. H.KimD. H.Constituents and the antitumor principle of Allium victorialis var. platyphyllum200124244450[PubMed]
26. ChiangH. C.LoY. J.LuF. J.Xanthine oxidase inhibitors from the leaves of Alsophila spinulosa (Hook) Tryon1994886171[PubMed]
27. ZhangY.LiuC.ZhangZ.WangJ.WuG.LiS.Comprehensive separation and identification of chemical constituents from Apocynum venetum leaves by high-performance counter-current chromatography and high performance liquid chromatography coupled with mass spectrometry201087887831493155[PubMed]
28. HuongN. T.CuN. K.QuyT. V.ZidornC.GanzeraM.StuppnerH.A new phenylpropanoid glycoside from Jasminum subtriplinerve Blume2008101010351038[PubMed]
29. KrastevaI.PlatikanovS.NikolovS.KalogaM.Flavonoids from Astragalus hamosus20072121392395[PubMed]
30. KiemP. V.MinhC. V.HuongH. T.LeeJ. J.KimY. H.Caesaldecan, a cassane diterpenoid from the leaves of Caesalpinia decapetala20055353428430[PubMed]
31. AhmedH.MoawadA.OwisA.AbouZidS.AhmedO.Flavonoids of Calligonum polygonoides and their cytotoxicity2016545421192126[PubMed]
32. ChungD. W.LeeS. B.Novel synthesis of leucoside by enzymatic hydrolysis of tea seed extract20139393362367[PubMed]
33. LeeH. B.KimE. K.ParkS. J.BangS. G.KimT. G.ChungD. W.Isolation and anti-inflammatory effect of astragalin synthesized by enzymatic hydrolysis of tea seed extract2011919123152321[PubMed]
34. LeeH. B.KimE. K.ParkS. J.BangS. G.KimT. G.ChungD. W.Isolation and characterization of nicotiflorin obtained by enzymatic hydrolysis of two precursors in tea seed extract2010585848084813[PubMed]
35. LuoZ. M.LingT. J.LiL. X.A new norisoprenoid and other compounds from Fuzhuan brick tea2012171735393546[PubMed]
36. FengW. S.HaoZ. Y.ZhengX. K.KuangH. X.Chemical constituents from leaves of Celastrus gemmatus Loes20074242625630
37. NhiemN. X.TaiB. H.QuangT. H.A new ursane-type triterpenoid glycoside from Centella asiatica leaves modulates the production of nitric oxide and secretion of TNF-α in activated RAW 264.7 cells2011212117771781[PubMed]
38. Van OanhH.SinhP. X.AnN. T.A new rearranged abietane diterpene and other constituents from Clerodendrum philipinum200944323325
39. CalzadaF.Cedillo-RiveraR.MataR.Antiprotozoal activity of the constituents of Conyza filaginoides20016464671673[PubMed]
40. YoshikawaM.ShimadaH.SakaM.YoshizumiS.YamaharaJ.MatsudaH.Medicinal foodstuffs. V. Moroheiya. (1): absolute stereostructures of corchoionosides A, B, and C, histamine release inhibitors from the leaves of Vietnamese Corchorus olitorius L. (Tiliaceae)19974545464469[PubMed]
41. YeM.YanY.GuoD. A.Characterization of phenolic compounds in the Chinese herbal drug Tu-Si-Zi by liquid chromatography coupled to electrospray ionization mass spectrometry2005191914691484[PubMed]
42. GuoH.LiJ.Flavonoids of Cuscuta australis R. Br199722223839
43. HeX.YangW.YeM.WangQ.GuoD.Differentiation of Cuscuta chinensis and Cuscuta australis by HPLC-DAD-MS analysis and HPLC-UV quantitation2011777719501957[PubMed]
44. LeeJ. H.KuC. H.BaekN. I.KimS. H.ParkH. W.KimD. K.Phytochemical constituents from Diodia teres200427274043[PubMed]
45. BraunbergerC.ZehlM.ConradJ.LC-NMR, NMR, and LC-MS identification and LC-DAD quantification of flavonoids and ellagic acid derivatives in Drosera peltata2013932932111116[PubMed]
46. CordellG. A.LyonR. L.FongH. H.BenoitP. S.FarnsworthN. R.Biological and phytochemical investigations of Dianthus barbatus cv. “China Doll” (Caryophyllaceae)19774040361363
47. KimH. Y.MoonB. H.LeeH. J.ChoiD. H.Flavonol glycosides from the leaves of Eucommia ulmoides O. with glycation inhibitory activity20049393227230[PubMed]
48. ChengJ.ZhaoY. Y.CuiY. X.ChengT. M.Studies on flavonoids from leave of Eucommia ulmoides Oliv20002525284286
49. LiX.TangZ.FeiD.LiuY.ZhangM.LiuS.Evaluation of the sedative and hypnotic effects of astragalin isolated from Eucommia ulmoides leaves in mice2017313120722076[PubMed]
50. ElemaE. T.SchripsemaJ.MalingreT. M.Flavones and flavonol glycosides from Eupatorium cannabinum L19891111161164[PubMed]
51. QianS. H.YangN. Y.DuanJ. A.YuanL. H.TianL. J.Study on the flavonoids of Eupatorium lindleyanum200429295052
52. ZhangJ.LiX.RenL.FangC.WangF.Chemical constituents from Exochorda racemosa2011363611981201
53. XieQ.DingL.WeiY.ItoY.Determination of major components and fingerprint analysis of Flaveria bidentis (L.) Kuntze20145252252257[PubMed]
54. WeiY.XieQ.FisherD.SutherlandI. A.Separation of patuletin-3-O-glucoside, astragalin, quercetin, kaempferol and isorhamnetin from Flaveria bidentis (L.) Kuntze by elution-pump-out high-performance counter-current chromatography2011121862066211[PubMed]
55. YangY.ZhaoY.GuD.Separation of the minor flavonols from Flos Gossypii by high-speed countercurrent chromatography2010333315021515[PubMed]
56. TaiZ. G.YangX. Q.CaiL.SunW. J.DingZ. T.YangY. B.Studies on the chemical constituents from the aerial parts of Gladiolus gandavensis2010333312571259
57. BiondiD. M.RoccoC.RubertoG.Dihydrostilbene derivatives from Glycyrrhiza glabra leaves2005686810991102[PubMed]
58. JiaS. S.MaC. M.LiY. H.HaoJ. H.Glycosides of phenolic acid and flavonoids from the leaves of Glycyrrhiza uralensis Ficsh19922727441444
59. AlgaririK.MengK. Y.AtangwhoI. J.Hypoglycemic and anti-hyperglycemic study of Gynura procumbens leaf extracts201333358366[PubMed]
60. TruteA.NahrstedtA.Identification and quantitative analysis of phenolic compounds from the dry extract of Hedera helix19976363177179[PubMed]
61. CalzadaF.AlanisA. D.Additional antiprotozoal flavonol glycosides of the aerial parts of Helianthemum glomeratum200721217880[PubMed]
62. RenY. L.YangJ. S.Study on chemical constituents of Hemistepta lyrata Bunge20013636746749
63. HeinaahoM.PuseniusJ.Julkunen-TiittoR.Effects of different organic farming methods on the concentration of phenolic compounds in sea buckthorn leaves2006545476787685[PubMed]
64. LuoJ. G.KongL. Y.Study on flavonoids from leaf of Ipomoea batatas20053030516518
65. QuQ. H.ZhangL.BaoH.ZhangJ. H.YouX. J.WangJ. X.Chemical constituents of flavonoids from flowers of Koelreuteria paniculata2011343417161719
66. BernaertN.WoutersD.De VuystL.Antioxidant changes of leek (Allium ampeloprasum var. porrum) during spontaneous fermentation of the white shaft and green leaves2013939321462153[PubMed]
67. RenD. C.YangN. Y.QianS. H.XieN.ZhouX. M.DuanJ. A.Chemical study on aerial parts of Ligusticum chuanxiong2007323214181420
68. XiaoM.CaoN.FanJ. J.ShenY.XuQ.Studies on flavonoids from the leaves of Lindera aggregata201134346264
69. YeH.YuJ.The preliminary studies on antioxidation of three kinds of flavoniods from Litsea coreana20042727113115
70. JungK. Y.OhS. R.ParkS. H.Anti-complement activity of tiliroside from the flower buds of Magnolia fargesii1998212110771078[PubMed]
71. VongsakB.SithisarnP.GritsanapanW.Simultaneous HPLC quantitative analysis of active compounds in leaves of Moringa oleifera Lam20145252641645[PubMed]
72. DoiK.KojimaT.MakinoM.KimuraY.FujimotoY.Studies on the constituents of the leaves of Morus alba L20014949151153[PubMed]
73. SugiyamaM.KatsubeT.KoyamaA.ItamuraH.Varietal differences in the flavonol content of mulberry (Morus spp.) leaves and genetic analysis of quercetin 3-(6-malonylglucoside) for component breeding2013616191409147[PubMed]
74. HeJ.FengY.OuyangH. Z.A sensitive LC-MS/MS method for simultaneous determination of six flavonoids in rat plasma: application to a pharmacokinetic study of total flavonoids from mulberry leaves20138484189195[PubMed]
75. ChoiJ.KangH. J.KimS. Z.KwonT. O.JeongS. I.JangS. I.Antioxidant effect of astragalin isolated from the leaves of Morus alba L. against free radical-induced oxidative hemolysis of human red blood cells20133636912917[PubMed]
76. ZouY.LiaoS.ShenW.Phenolics and antioxidant activity of mulberry leaves depend on cultivar and harvest month in Southern China201213131654416553[PubMed]
77. TaoY.ZhangY.ChengY.WangY.Rapid screening and identification of alpha-glucosidase inhibitors from mulberry leaves using enzyme-immobilized magnetic beads coupled with HPLC/MS and NMR20132727148155[PubMed]
78. KimS. Y.GaoJ. J.LeeW. C.RyuK. S.LeeK. R.KimY. C.Antioxidative flavonoids from the leaves of Morus alba199922228185[PubMed]
79. RanariveloY.SkaltsounisA. L.AndriantsiferanaM.TillequinF.Glycosides from Mussaenda arcuata Lam. ex Poiret leaves19904848273277
80. OhkoshiE.MiyazakiH.ShindoK.WatanabeH.YoshidaA.YajimaH.Constituents from the leaves of Nelumbo nucifera stimulate lipolysis in the white adipose tissue of mice2007737312551259[PubMed]
81. TianN.LiuZ.HuangJ.LuoG.LiuS.LiuX.Isolation and preparation of flavonoids from the leaves of Nelumbo nucifera Gaertn by preparative reversed-phase high performance liquid chromatography200725258892
82. ZhaoX. L.WangZ. M.MaX. J.JingW. G.LiuA.Chemical constituents from leaves of Nelumbo nucifera20133838703708
83. XuS.SunY.JingF.DuanW.DuJ.WangX.Separation and purification of flavones from Nelumbo nucifera Gaertn. by silica gel chromatography and high-speed counter-current chromatography2011292912441248
84. DengS.DengZ.FanY.Isolation and purification of three flavonoid glycosides from the leaves of Nelumbo nucifera (Lotus) by high-speed counter-current chromatography200987787724872492[PubMed]
85. BarakatH. H.El-MousallamyA. M.SoulemanA. M.AwadallaS.Flavonoids of Ochradenus baccatus1991303037773779[PubMed]
86. Je MaC.JungW. J.LeeK. Y.KimY. C.SungS. H.Calpain inhibitory flavonoids isolated from Orostachys japonicus20092424676679[PubMed]
87. MatsumotoM.KotaniM.FujitaA.Oral administration of persimmon leaf extract ameliorates skin symptoms and transepidermal water loss in atopic dermatitis model mice, NC/Nga2002146146221227[PubMed]
88. XueY. L.MiyakawaT.HayashiY.Isolation and tyrosinase inhibitory effects of polyphenols from the leaves of persimmon, Diospyros kaki2011595960116017[PubMed]
89. KamedaK.TakakuT.OkudaH.Inhibitory effects of various flavonoids isolated from leaves of persimmon on angiotensin-converting enzyme activity19875050680683[PubMed]
90. MaZ.PiaoT.WangY.LiuJ.Astragalin inhibits IL-1β-induced inflammatory mediators production in human osteoarthritis chondrocyte by inhibiting NF-κB and MAPK activation201525258387[PubMed]
91. LiF.WangW.CaoY.Inhibitory effects of astragalin on lipopolysaccharide-induced inflammatory response in mouse mammary epithelial cells2014192192573581[PubMed]
92. LiF.LiangD.YangZ.Astragalin suppresses inflammatory responses via down-regulation of NF-κB signaling pathway in lipopolysaccharide-induced mastitis in a murine model20131717478482[PubMed]
93. Skalicka-WozniakK.SzypowskiJ.GlowniakK.HPLC analysis of kaempherol and quercetin derivatives isolated by different extraction techniques from plant matrix201194941721
94. LaparraJ. M.GlahnR. P.MillerD. D.Assessing potential effects of inulin and probiotic bacteria on Fe availability from common beans (Phaseolus vulgaris L.) to Caco-2 cells20097474H40H46[PubMed]
95. TakedaY.IsaiN.MasudaT.Phlomisflavosides A and B, new flavonol bisglycosides from Phlomis spinidens2001494910391041[PubMed]
96. AgyareC.LechtenbergM.DetersA.PetereitF.HenselA.Ellagitannins from Phyllanthus muellerianus (Kuntze) Exell.: Geraniin and furosin stimulate cellular activity, differentiation and collagen synthesis of human skin keratinocytes and dermal fibroblasts20111818617624[PubMed]
97. Klein-JuniorL. C.SantinJ. R.LemosM.Role of gastric mucus secretion, oxinitrergic system and sulfhydryl groups on the gastroprotection elicited by Polygala cyparissias (Polygalaceae) in mice20136565767776[PubMed]
98. CalisI.KuruuzumA.DemirezerL. O.SticherO.GanciW.RuediP.Phenylvaleric acid and flavonoid glycosides from Polygonum salicifolium1999626211011105[PubMed]
99. OlszewskaM. A.KwapiszA.Metabolite profiling and antioxidant activity of Prunus padus L. flowers and leaves2011252511151131[PubMed]
100. OlszewskaM.High-performance liquid chromatographic identification of flavonoid monoglycosides from Prunus serotina ehrh20056262435441
101. Krauze-BaranowskaM.SowinskiP.KawiakA.SparzakB.Flavonoids from Pseudotsuga menziesii201368688796[PubMed]
102. KwonH. J.ParkY. D.Determination of astragalin and astragaloside content in Radix astragali using high-performance liquid chromatography coupled with pulsed amperometric detection20121232212217[PubMed]
103. JianJ.WuZ.Influences of traditional Chinese medicine on non-specific immunity of Jian Carp (Cyprinus carpio var. Jian)20041616185191[PubMed]
104. LiG.GaoT.WenJ.YangR.YuC.ZhangS.A research on the quality of radix Astragali19921717454456
105. DingY.NguyenH. T.ChoiE. M.BaeK.KimY. H.Rhusonoside A, a new megastigmane glycoside from Rhus sylvestris, increases the function of osteoblastic MC3T3-E1 cells20097575158162[PubMed]
106. YangC.LiF.ZhangX.WangL.ZhouZ.WangM.Phenolic antioxidants from Rosa soulieana flowers2013272720552058[PubMed]
107. NguelefackT. B.MbakamF. H.TapondjouL. A.A dimeric triterpenoid glycoside and flavonoid glycosides with free radical-scavenging activity isolated from Rubus rigidus var. camerunensis20113434543550[PubMed]
108. WangH. Q.ZhaoC. Y.ChenR. Y.Studies on chemical constituents from leaves of Sapium sebiferum2007323211791181
109. KamelM. S.OhtaniK.HasanainH. A.MohamedM. H.KasaiR.YamasakiK.Monoterpene and pregnane glucosides from Solenostemma argel20005353937940[PubMed]
110. ApatiP.HoughtonP. J.KeryA.HPLC investigation of antioxidant components in Solidago herba20047474223231
111. OlszewskaM. A.MichelP.Activity-guided isolation and identification of free radical-scavenging components from various leaf extracts of Sorbus aria (L.) Crantz20122626243254[PubMed]
112. XiangW.LiR. T.MaoY. L.Four new prenylated isoflavonoids in Tadehagi triquetrum20055353267271[PubMed]
113. ShenG.OhS. R.MinB. S.Phytochemical investigation of Tiarella polyphylla200831311016[PubMed]
114. HosoiS.ShimizuE.OhnoK.Structural studies of zoospore attractants from Trachelospermum jasminoides var. pubescens: taxifolin 3-O-glycosides200617172024[PubMed]
115. AishanH.BabaM.IwasakiN.KuangH.OkuyamaT.The constituents of Urtica cannabina used in Uighur medicine20104848577583[PubMed]
116. MajindaR. R.MotswalediM.WaighR. D.WatermanP. G.Phenolic and antibacterial constituents of Vahlia capensis19976363268270[PubMed]
117. SingabA. N.YoussefD. T.NoamanE.KotbS.Hepatoprotective effect of flavonol glycosides rich fraction from Egyptian Vicia calcarata Desf. against CCl4-induced liver damage in rats20052828791798[PubMed]
118. ApersS.HuangY.Van MiertS.Characterisation of new oligoglycosidic compounds in two Chinese medicinal herbs20021313202206[PubMed]
119. WeissU.Inflammation2008454454p. 427[PubMed]
120. SarfrazI.RasulA.JabeenF.Fraxinus: a plant with versatile pharmacological and biological activities2017201712[PubMed]
121. WalkerJ.ReicheltK. V.ObstK.Identification of an anti-inflammatory potential of Eriodictyon angustifolium compounds in human gingival fibroblasts20167730463055[PubMed]
122. SoromouL. W.ChenN.JiangL.Astragalin attenuates lipopolysaccharide-induced inflammatory responses by down-regulating NF-κB signaling pathway2012419419256261[PubMed]
123. ChoiE. J.LeeS.ChaeJ. R.LeeH. S.JunC. D.KimS. H.Eupatilin inhibits lipopolysaccharide-induced expression of inflammatory mediators in macrophages2011888811211126[PubMed]
124. ZhangW.LuX.WangW.Inhibitory effects of emodin, thymol, and astragalin on leptospira interrogans-induced inflammatory response in the uterine and endometrium epithelial cells of mice20174040666675[PubMed]
125. InabaH.TagashiraM.HonmaD.Identification of hop polyphenolic components which inhibit prostaglandin E2 production by gingival epithelial cells stimulated with periodontal pathogen20083131527530[PubMed]
126. LiuJ.ChengY.ZhangX.Astragalin attenuates allergic inflammation in a murine asthma model2015383820072016[PubMed]
127. KimM. S.KimS. H.Inhibitory effect of astragalin on expression of lipopolysaccharide-induced inflammatory mediators through NF-κB in macrophages2011343421012107[PubMed]
128. WangZ.LiQ.XiangM.Astragaloside alleviates hepatic fibrosis function via PAR2 signaling pathway in diabetic rats2017414111561166[PubMed]
129. ChoI. H.GongJ. H.KangM. K.Astragalin inhibits airway eotaxin-1 induction and epithelial apoptosis through modulating oxidative stress-responsive MAPK signaling20141414p. 122[PubMed]
130. LiH.ShiR.DingF.Astragalus polysaccharide suppresses 6-hydroxydopamine-induced neurotoxicity in Caenorhabditis elegans20162016p. 4856761[PubMed]
131. YanL.ZhouQ. H.Study on neuroprotective effects of astragalan in rats with ischemic brain injury and its mechanisms20122828373377
132. ChoI. H.ChoiY. J.GongJ. H.ShinD.KangM. K.KangY. H.Astragalin inhibits autophagy-associated airway epithelial fibrosis20151616p. 51[PubMed]
133. WasikA.Antkiewicz-MichalukL.The mechanism of neuroprotective action of natural compounds20176969851860[PubMed]
134. HabertheuerA.KocherA.LauferG.Cardioprotection: a review of current practice in global ischemia and future translational perspective2014201411[PubMed]
135. TanakaK.KerstenJ. R.RiessM. L.Opioid-induced cardioprotection2014202056965705[PubMed]
136. TestaiL.Flavonoids and mitochondrial pharmacology: A new paradigm for cardioprotection20151351356876[PubMed]
137. QuD.HanJ.RenH.Cardioprotective effects of astragalin against myocardial ischemia/reperfusion injury in isolated rat heart2016201611[PubMed]
138. WangS.Moustaid-MoussaN.ChenL.Novel insights of dietary polyphenols and obesity20142525118[PubMed]
139. AlamU.AsgharO.AzmiS.MalikR. A.General aspects of diabetes mellitus2014126126211222[PubMed]
140. JungM.ParkM.LeeH. C.KangY. H.KangE. S.KimS. K.Antidiabetic agents from medicinal plants2006131312031218[PubMed]
141. KeM.HuX. Q.OuyangJ.DaiB.XuY.The effect of astragalin on the VEGF production of cultured Muller cells under high glucose conditions20122222113119
142. KimG. E.KangH. K.SeoE. S.Glucosylation of the flavonoid, astragalin by Leuconostoc mesenteroides B-512FMCM dextransucrase acceptor reactions and characterization of the products201250505056[PubMed]
143. JungS. Y.JungW. S.JungH. K.The mixture of different parts of Nelumbo nucifera and two bioactive components inhibited tyrosinase activity and melanogenesis20146565377388
144. SvobodovaA.PsotovaJ.WalterovaD.Natural phenolics in the prevention of UV-induced skin damage. A review2003147147137145[PubMed]
145. ChenM.CaiF.ZhaD.Astragalin-induced cell death is caspase-dependent and enhances the susceptibility of lung cancer cells to tumor necrosis factor by inhibiting the NF-κB pathway2017882694126958[PubMed]
146. RasoolM.MalikA.MananA.Roles of natural compounds from medicinal plants in cancer treatment: structure and mode of action at molecular level20151111618628[PubMed]
147. NeergheenV. S.BahorunT.TaylorE. W.JenL. S.AruomaO. I.Targeting specific cell signaling transduction pathways by dietary and medicinal phytochemicals in cancer chemoprevention2010278278229241[PubMed]
148. JafariS.SaeidniaS.AbdollahiM.Role of natural phenolic compounds in cancer chemoprevention via regulation of the cell cycle20141515409421[PubMed]
149. SunJ.LiF.ZhaoY.LZ-207, a newly synthesized flavonoid, induces apoptosis and suppresses inflammation-related colon cancer by inhibiting the NF-κB signaling pathway20151010[PubMed]
150. LiW.HaoJ.ZhangL.ChengZ.DengX.ShuG.Astragalin reduces hexokinase 2 through increasing miR-125b to inhibit the proliferation of hepatocellular carcinoma cells in vitro and in vivo2017656559615972[PubMed]
151. YouO. H.ShinE. A.LeeH.Apoptotic effect of astragalin in melanoma skin cancers via activation of caspases and inhibition of Sry-related HMg-box gene 102017313116141620[PubMed]
152. ZhangJ.LiN.ZhangK.Astragalin attenuates UVB radiation-induced actinic keratosis formation2017In Press
153. ChiangY. Y.WangS. L.YangC. L.Extracts of Koelreuteria henryi Dummer induce apoptosis and autophagy by inhibiting dihydrodiol dehydrogenase, thus enhancing anticancer effects20133232577584[PubMed]
154. AmmarO.In silico pharmacodynamics, toxicity profile and biological activities of the Saharan medicinal plant Limoniastrum feei20175353110[PubMed]